SRTS vs. ICCM, AMIX, SEPA, HSAQ, CTSO, DXR, NSPR, APYX, PDEX, and XAIR
Should you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include IceCure Medical (ICCM), Autonomix Medical (AMIX), SEP Acquisition (SEPA), Health Sciences Acquisitions Co. 2 (HSAQ), Cytosorbents (CTSO), Daxor (DXR), InspireMD (NSPR), Apyx Medical (APYX), Pro-Dex (PDEX), and Beyond Air (XAIR). These companies are all part of the "surgical & medical instruments" industry.
IceCure Medical (NASDAQ:ICCM) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.
0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 11.1% of Sensus Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, IceCure Medical and IceCure Medical both had 2 articles in the media. IceCure Medical's average media sentiment score of 0.85 beat Sensus Healthcare's score of 0.50 indicating that Sensus Healthcare is being referred to more favorably in the news media.
Sensus Healthcare has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Sensus Healthcare, indicating that it is currently the more affordable of the two stocks.
IceCure Medical has a beta of 0.73, indicating that its share price is 27% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500.
Sensus Healthcare has a net margin of 1.99% compared to Sensus Healthcare's net margin of -453.76%. IceCure Medical's return on equity of 1.04% beat Sensus Healthcare's return on equity.
Sensus Healthcare received 159 more outperform votes than IceCure Medical when rated by MarketBeat users. However, 94.44% of users gave IceCure Medical an outperform vote while only 67.69% of users gave Sensus Healthcare an outperform vote.
IceCure Medical currently has a consensus price target of $2.95, indicating a potential upside of 146.41%. Sensus Healthcare has a consensus price target of $7.50, indicating a potential upside of 120.59%. Given Sensus Healthcare's higher possible upside, analysts plainly believe IceCure Medical is more favorable than Sensus Healthcare.
Summary
Sensus Healthcare beats IceCure Medical on 12 of the 16 factors compared between the two stocks.
Get Sensus Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sensus Healthcare Competitors List
Related Companies and Tools
